RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.1055%2Fs-0043-107242
https://w3id.org/ripe/ripe-kg/work/10.1055%2Fs-0043-107242
| Subject | Predicate | Object |
|---|---|---|
ripekg:peer-comment/RIPEA068C16C1B806E52A-1 |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:peer-comment/RIPEA068C16C1B806E52A-1 |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:peer-comment/RIPEA72DC7586F4A2C751-1 |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:peer-comment/RIPEA72DC7586F4A2C751-1 |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:publication-details/RIPEA068C16C1B806E52AThe Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:publication-details/RIPEA068C16C1B806E52AThe Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:publication-details/RIPEA72DC7586F4A2C751The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:publication-details/RIPEA72DC7586F4A2C751The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:registry-evidence/RIPEA068C16C1B806E52A |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:registry-evidence/RIPEA068C16C1B806E52A |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:registry-evidence/RIPEA72DC7586F4A2C751 |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:registry-evidence/RIPEA72DC7586F4A2C751 |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:research-integrity-assessment/RIPEA068C16C1B806E52A |
ripe:assesses |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:research-integrity-assessment/RIPEA068C16C1B806E52A |
ripe:assesses |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripe:assesses |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripe:assesses |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:study-design-evidence/RIPEA068C16C1B806E52A |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:study-design-evidence/RIPEA068C16C1B806E52A |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:study-design-evidence/RIPEA72DC7586F4A2C751 |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:study-design-evidence/RIPEA72DC7586F4A2C751 |
ripe:concerns |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1007%2Fs00394-018-1760-8Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:work/10.1007%2Fs00394-018-1760-8Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
prism:doi |
10.1055/s-0043-107242 |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prism:doi |
10.1055/s-0043-107242 |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
dcterms:creator |
ripekg:author/RIPEAU2800E4CE5C23C69BZatollah Asemi |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
dcterms:creator |
ripekg:author/RIPEAU2800E4CE5C23C69BZatollah Asemi |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
dcterms:creator |
ripekg:author/RIPEAU9E737EF8E324D850Maryam Chamani |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
dcterms:creator |
ripekg:author/RIPEAU9E737EF8E324D850Maryam Chamani |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
dcterms:creator |
ripekg:author/RIPEAUAB73CBCED971D8CEMaryam Maktabi |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
dcterms:creator |
ripekg:author/RIPEAUAB73CBCED971D8CEMaryam Maktabi |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
dcterms:title |
The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
dcterms:title |
The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
dcterms:title |
The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
dcterms:title |
The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/10.1111%2F1756-185x.12770Role of vitamin D supplementation in improving disease activity in rheumatoid arthritis: An exploratory study |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/10.1111%2F1756-185x.12770Role of vitamin D supplementation in improving disease activity in rheumatoid arthritis: An exploratory study |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW002FD477CA3E794AThe eff ects of vitamin D supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW002FD477CA3E794AThe eff ects of vitamin D supplementation on wound healing and metabolic status in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW04ADAB8FE14B8074Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW04ADAB8FE14B8074Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW12A2E8806F2556B5Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW12A2E8806F2556B5Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW1553DDBCC610FC97Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW1553DDBCC610FC97Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW21605103A95AEBA4Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW21605103A95AEBA4Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW25C221822B0513B5Hirsutism: implications, etiology, and management |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW25C221822B0513B5Hirsutism: implications, etiology, and management |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW30AD68F52E0FB3D9DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: A randomized controlled clinical trial |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW30AD68F52E0FB3D9DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW30AD68F52E0FB3D9DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: A randomized controlled clinical trial |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW30AD68F52E0FB3D9DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW3667CAADE74D4F28The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW3667CAADE74D4F28The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW4475B649DA8DA4E8Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: Impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW4475B649DA8DA4E8Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW4475B649DA8DA4E8Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: Impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW4475B649DA8DA4E8Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW4C0B8D115854A9EANational Alopecia Areata Foundation. Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW4C0B8D115854A9EANational Alopecia Areata Foundation. Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW57D990A81002EDAFPolycystic ovary syndrome and cardiovascular disease: a premature association? |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW57D990A81002EDAFPolycystic ovary syndrome and cardiovascular disease: a premature association? |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW5AAA2B34A8DD1999A simple and inexpensive automated technique for measurement of serum nitrite/nitrate |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW5AAA2B34A8DD1999A simple and inexpensive automated technique for measurement of serum nitrite/nitrate |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW6FAD0A2B53B2D5C5Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW6FAD0A2B53B2D5C5Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW73DEE0B4E09C5ECAMetabolic response to selenium supplementation in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW73DEE0B4E09C5ECAMetabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW73DEE0B4E09C5ECAMetabolic response to selenium supplementation in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW73DEE0B4E09C5ECAMetabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW74C52D3C8F63F07EEff ect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: A pilot study |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW74C52D3C8F63F07EEff ect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: A pilot study |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW796173AED9299B68The eff ect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW796173AED9299B68The eff ect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW7B6538C9515C6AF0Biomarkers and insulin sensitivity in women with PCOS: Characteristics and predictive capacity |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW7B6538C9515C6AF0Biomarkers and insulin sensitivity in women with PCOS: Characteristics and predictive capacity |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW7BD0BFF2F4F52110The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: A community based study in Southwest of Iran |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW7BD0BFF2F4F52110The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: A community based study in Southwest of Iran |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW7F47286D20AD4EF2A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW7F47286D20AD4EF2A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW8681B0261ABD487FEsmaillzadeh A. Calcium plus vitamin D supplementation aff ects glucose metabolism and lipid concentrations in overweight and obese vitamin D defi cient women with polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW8681B0261ABD487FEsmaillzadeh A. Calcium plus vitamin D supplementation aff ects glucose metabolism and lipid concentrations in overweight and obese vitamin D defi cient women with polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW8BDBB06E4D1995EDPlasma glutathione in health and in patients with malignant disease |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW8BDBB06E4D1995EDPlasma glutathione in health and in patients with malignant disease |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW8D7E37067B95F9CFEff ects of vitamin D supplementation on glucose metabolism, lipid concentrations, infl ammation, and oxidative stress in gestational diabetes: A double-blind randomized controlled clinical trial |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW8D7E37067B95F9CFEff ects of vitamin D supplementation on glucose metabolism, lipid concentrations, infl ammation, and oxidative stress in gestational diabetes: A double-blind randomized controlled clinical trial |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW9B4F6C2DC30A0B45Vitamin D defi ciency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW9B4F6C2DC30A0B45Vitamin D defi ciency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW9D57B28BF6FC856AExploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfl uorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: A case-control study |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW9D57B28BF6FC856AExploring the potential association between brominated diphenyl ethers, polychlorinated biphenyls, organochlorine pesticides, perfl uorinated compounds, phthalates, and bisphenol A in polycystic ovary syndrome: A case-control study |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWBA66324BF026A5F3Vitamin d defi ciency and endothelial dysfunction in rheumatoid arthritis patients |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWBA66324BF026A5F3Vitamin d defi ciency and endothelial dysfunction in rheumatoid arthritis patients |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWC5487AE8A3708039Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWC5487AE8A3708039Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWCCAE6E290C2CF156Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWCCAE6E290C2CF156Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWCF2C1396F48ABAC4Eff ect of Vitamin D Supplementation on C-reactive Protein in Patients with Nonalcoholic Fatty Liver |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWCF2C1396F48ABAC4Eff ect of Vitamin D Supplementation on C-reactive Protein in Patients with Nonalcoholic Fatty Liver |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWF01EBB61ADD88251Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWF01EBB61ADD88251Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWF14D3EC92BE18265Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWF14D3EC92BE18265Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWF42CDB8E64AE7F01The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWF42CDB8E64AE7F01The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWF83A7842B96A7144Vitamin D supplementation has no eff ect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D defi ciency |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWF83A7842B96A7144Vitamin D supplementation has no eff ect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D defi ciency |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWFE01E2C239193972Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3) |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWFE01E2C239193972Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3) |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
rdf:type |
node1 |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
node1 |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
rdf:type |
rdfs:Resource |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
rdfs:Resource |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
rdf:type |
owl:Thing |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
owl:Thing |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
rdf:type |
prov:Entity |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
prov:Entity |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
owl:sameAs |
https://semopenalex.org/work/W2733194357 |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
owl:sameAs |
https://semopenalex.org/work/W2733194357 |